Drug-Induced Liver Injury: The Role of Drug Metabolism and Transport

作者: Alberto Corsini , Michele Bortolini

DOI: 10.1002/JCPH.23

关键词:

摘要: … CYP3A4 has the highest abundance of all CYP450 enzymes in the human liver, although its expression … Metabolic enzymes involved in Phase II reactions include uridine diphosphate …

参考文章(162)
E. H. Liu, C-N. Lee, Y-C. Lin, M-C. Yu, K-J. Bai, H-Y. Chen, J-C. Chang, UGT1A1 polymorphisms associated with risk of induced liver disorders by anti-tuberculosis medications. International Journal of Tuberculosis and Lung Disease. ,vol. 16, pp. 376- 378 ,(2012) , 10.5588/IJTLD.11.0404
Zhan S, Sun F, Chen Y, Xiang Y, Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis. International Journal of Tuberculosis and Lung Disease. ,vol. 12, pp. 994- 1002 ,(2008)
SW Lee, L Chung, HH Huang, TY Chuang, YH Liou, L Wu, NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis. International Journal of Tuberculosis and Lung Disease. ,vol. 14, pp. 622- 626 ,(2010)
Agnés Poirier, Thierry Lavé, Johannes Noé, Christoph Funk, New strategies to address drug-drug interactions involving OATPs. Current Opinion in Drug Discovery & Development. ,vol. 10, pp. 74- 83 ,(2007)
Andreas Limmer, Jutta Ohl, Christian Kurts, Hans-Gustaf Ljunggren, Yuval Reiss, Marcus Groettrup, Frank Momburg, Bernd Arnold, Percy A. Knolle, Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nature Medicine. ,vol. 6, pp. 1348- 1354 ,(2000) , 10.1038/82161
S. Chatterjee, N. Lyle, A. Mandal, S. Kundu, GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs. Journal of Clinical Pharmacy and Therapeutics. ,vol. 35, pp. 465- 470 ,(2010) , 10.1111/J.1365-2710.2009.01101.X
Hansruedi Glatt, Sulfation and sulfotransferases 4: bioactivation of mutagens via sulfation. The FASEB Journal. ,vol. 11, pp. 314- 321 ,(1997) , 10.1096/FASEBJ.11.5.9141497
SLCO1B1 variants and statin-induced myopathy--a genomewide study The New England Journal of Medicine. ,vol. 359, pp. 789- 799 ,(2008) , 10.1056/NEJMOA0801936